Encorafenib

• Description:

  LGX818 is an orally available mutated BRaf V600E inhibitor (IC50=0.3 nM) with potential antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  540.01

• Molecular Formula:

  C22H27ClFN7O4S

• Notes:

  Research use only, not for human use.

• Receptor:

  B-Raf (V600E)

• CAS Number:

  1269440-17-6